Symposiet Targeted therapy in B-cell malignances anordnas vid Nobelforum, Karolinska institutet, Stockholm, den 29-30 september 2016. För detaljerat program och anmälan, se symposiets webbplats.
Organisatörerna Richard Rosenquist Brandell och Karin Ekström Smedby sammanfattar:
We are glad to be able to announce a high-quality program covering the full spectrum from experimental, translational and clinical studies to state-of-the-art treatment of B-cell malignancies. The symposium is sponsored by the Journal of Internal Medicine.
The program includes Key-note speakers NIH Distinguished Investigator Louis M. Staudt from the National Cancer Institute (Bethesda), Professor Susan O’Brien from University of California (Irvine), and Professor Riccardo Dalla-Favera from Columbia University (New York), as well as other prominent researchers from the UK, France, Germany, Greece, Spain, Italy and Sweden.